DrugPatentWatch Database Preview
Alemtuzumab - Biologic Drug Details
Summary for alemtuzumab
| Tradenames: | 2 |
| Patents: | 303 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for alemtuzumab |
Pharmacology for alemtuzumab
| Mechanism of Action | CD52-directed Antibody Interactions |
US Patents for alemtuzumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | IBC Pharmaceuticals, Inc. (Morris Plains, NJ) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | University of Georgia Research Foundation, Inc. (Athens, GA) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | AbbVie Stemcentrx LLC (North Chicago, IL) | ➤ Try a Free Trial | RX | Orphan | search |
| Genzyme | CAMPATH | alemtuzumab | VIAL; INTRAVENOUS | 103948 | 001 | 2001-05-07 | ➤ Try a Free Trial | University of the Sciences of Philadelphia (Philadelphia, PA) | ➤ Try a Free Trial | RX | Orphan | search |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for alemtuzumab
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 6277121 | ➤ Try a Free Trial |
| Finland | 894479 | ➤ Try a Free Trial |
| Australia | 2015243379 | ➤ Try a Free Trial |
| Mexico | 2010000474 | ➤ Try a Free Trial |
| Japan | 2018110588 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for alemtuzumab
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2015000061 | Germany | ➤ Try a Free Trial | PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826 |
| 199051 | Germany | ➤ Try a Free Trial | PRODUCT NAME: MABCAMPATH-ALEMTUZUMAB IN ALLEN SEINEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/01/193/001 20010706 |
| 2016 00031 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; NAT. REG. NO/DATE: EU/1/98/067/003-004 20140326; FIRST REG. NO/DATE: EU EU/1/98/067 20140326 |
| /2001 | Austria | ➤ Try a Free Trial | PRODUCT NAME: ALEMTUZUMAB; REGISTRATION NO/DATE: EU/1/01/193/001 20010706 |
| 0067 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ALEMTUZUMAB; REGISTRATION NO/DATE: EU/1/01/193/001 20010706 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
